Free Trial

Siemens Fonds Invest GmbH Has $480,000 Position in Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background

Siemens Fonds Invest GmbH decreased its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 78.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,282 shares of the company's stock after selling 18,842 shares during the quarter. Siemens Fonds Invest GmbH's holdings in Colgate-Palmolive were worth $480,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in CL. GHE LLC grew its position in Colgate-Palmolive by 1.7% during the 4th quarter. GHE LLC now owns 21,288 shares of the company's stock worth $1,935,000 after purchasing an additional 350 shares in the last quarter. Menard Financial Group LLC purchased a new position in Colgate-Palmolive during the 4th quarter worth approximately $102,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Colgate-Palmolive during the 4th quarter worth approximately $97,950,000. Leigh Baldwin & CO. LLC purchased a new position in Colgate-Palmolive during the 4th quarter worth approximately $422,000. Finally, Hall Capital Management Co. Inc. purchased a new position in Colgate-Palmolive during the 4th quarter worth approximately $308,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Wells Fargo & Company boosted their price target on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a report on Wednesday, April 2nd. Raymond James restated an "outperform" rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. UBS Group boosted their price target on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the company a "buy" rating in a report on Thursday, April 17th. Barclays lowered their price target on shares of Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a report on Friday, April 11th. Finally, Morgan Stanley lowered their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $102.12.

View Our Latest Report on CL

Colgate-Palmolive Stock Down 1.4%

Shares of CL stock traded down $1.31 on Tuesday, hitting $90.62. The company's stock had a trading volume of 4,775,883 shares, compared to its average volume of 4,698,752. The stock has a market capitalization of $73.44 billion, a price-to-earnings ratio of 25.74, a P/E/G ratio of 4.20 and a beta of 0.39. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The firm's fifty day moving average price is $91.97 and its 200-day moving average price is $91.25.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, topping analysts' consensus estimates of $0.86 by $0.05. The firm had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.92 billion. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The business's revenue was down 3.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.86 EPS. Research analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th were given a dividend of $0.52 per share. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. The ex-dividend date of this dividend was Thursday, April 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.30%. Colgate-Palmolive's payout ratio is currently 58.76%.

Colgate-Palmolive declared that its board has authorized a share buyback program on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to buy up to 6.8% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's board of directors believes its shares are undervalued.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines